Alpa Laboratories share news, announcements and annual reports
NSE: ALPABSE: 532878Pharmaceuticals & BiotechnologySmall Cap
Alpa Laboratories Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Aug 2007
Last close ₹50.38down ₹2.24 (4.26%)BSE ₹49.80
Share price at the NSE close on 30 Oct 2026. Previous close ₹52.62.
30 Oct: open ₹51.50, high ₹51.65, low ₹50.00
52-week range of traded prices to 30 Oct 2026
₹46.10Low, 30 Mar 2026₹93.85High, 31 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹106 Cr2,659th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.57
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −1.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.01
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 17,77166.0% delivered
Alpa Laboratories share news and announcements
363 announcements, routine notices left out, newest first. Page 4 of 8.
Sep 2020
Aug 2020
25 Aug · Results
13 Aug · Board meeting
8 Aug · Legal
The exchange asked on 4 Aug 2020
Jul 2020
28 Jul · Legal
Exchange has sought clarification from Alpa Laboratories Limited for the quarter ended 31-Mar-2020 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. The company has not submitted the Statement of Modified Opinion or in case of unmodified opinion(s), a declaration to that effect to the Stock Exchange. -2. Financial results submitted is not as per format prescribed by SEBI The response of the Company is awaited.
Jun 2020
30 Jun · Results
29 Jun · Board meeting
22 Jun · Board meeting
Apr 2020
13 Apr · Legal
The exchange asked on 9 Apr 2020
8 Apr · Disclosure
Feb 2020
13 Feb · Results
1 Feb · Board meeting
Jan 2020
22 Jan · Legal
The exchange asked on 20 Jan 2020
Dec 2019
Nov 2019
13 Nov · Legal
Exchange has sought clarification from Alpa Laboratories Limited for the quarter ended 30-Sep-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Statement of Cash Flow not submitted The response of the Company is awaited.12 Nov · Results
5 Nov · Legal
The exchange asked on 5 Nov 2019
Oct 2019
31 Oct · Board meeting
Sep 2019
Aug 2019
19 Aug · Legal
Exchange has sought clarification from Alpa Laboratories Limited for the quarter ended 30-Jun-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is awaited.14 Aug · Results
2 Aug · Board meeting
Jul 2019
24 Jul · Legal
The exchange asked on 23 Jul 2019
Jun 2019
May 2019
27 May · Results
13 May · Board meeting
Apr 2019
Feb 2019
9 Feb · Results
Jan 2019
31 Jan · Board meeting
Nov 2018
5 Nov · Results
Oct 2018
23 Oct · Board meeting
Sep 2018
29 Sep · Meeting
Aug 2018
13 Aug · Results
Jul 2018